A citation-based method for searching scientific literature

Bjoern Chapuy, Margaretha G M Roemer, Chip Stewart, Yuxiang Tan, Ryan P Abo, Liye Zhang, Andrew J Dunford, David M Meredith, Aaron R Thorner, Ekaterina S Jordanova, Gang Liu, Friedrich Feuerhake, Matthew D Ducar, Gerald Illerhaus, Daniel Gusenleitner, Erica A Linden, Heather H Sun, Heather Homer, Miyuki Aono, Geraldine S Pinkus, Azra H Ligon, Keith L Ligon, Judith A Ferry, Gordon J Freeman, Paul van Hummelen, Todd R Golub, Gad Getz, Scott J Rodig, Daphne de Jong, Stefano Monti, Margaret A Shipp. Blood 2016
Times Cited: 305



R Eric Davis, Vu N Ngo, Georg Lenz, Pavel Tolar, Ryan M Young, Paul B Romesser, Holger Kohlhammer, Laurence Lamy, Hong Zhao, Yandan Yang, Weihong Xu, Arthur L Shaffer, George Wright, Wenming Xiao, John Powell, Jian-Kang Jiang, Craig J Thomas, Andreas Rosenwald, German Ott, Hans Konrad Muller-Hermelink, Randy D Gascoyne, Joseph M Connors, Nathalie A Johnson, Lisa M Rimsza, Elias Campo, Elaine S Jaffe, Wyndham H Wilson, Jan Delabie, Erlend B Smeland, Richard I Fisher, Rita M Braziel, Raymond R Tubbs, J R Cook, Dennis D Weisenburger, Wing C Chan, Susan K Pierce, Louis M Staudt. Nature 2010
Times Cited: 1108




List of shared articles



Times cited

Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?
Ryan D Morin, Sarah E Arthur, Daniel J Hodson. Br J Haematol 2022
9

Targetable alterations in primary extranodal diffuse large B-cell lymphoma.
Stephanie E Weissinger, Rucha Dugge, Miriam Disch, Thomas F Barth, Johannes Bloehdorn, Malena Zahn, Ralf Marienfeld, Andreas Viardot, Peter Möller. EJHaem 2022
0

0

Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma.
Julia Garcia-Reyero, Nerea Martinez Magunacelaya, Sonia Gonzalez de Villambrosia, Sanam Loghavi, Angela Gomez Mediavilla, Raul Tonda, Sergi Beltran, Marta Gut, Ainara Pereña Gonzalez, Emanuele d'Ámore,[...]. Haematologica 2021
19


Molecular classification of aggressive lymphomas-past, present, future.
Kirsty Wienand, Björn Chapuy. Hematol Oncol 2021
3

Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development.
Kensuke Tateishi, Yohei Miyake, Taishi Nakamura, Tetsuya Yamamoto. Brain Tumor Pathol 2021
3

Targeting Bruton's tyrosine kinase in primary central nervous system lymphoma.
Sara Steffanoni, Tracy T Batchelor. Curr Opin Neurol 2021
0

Prevalence and prognostic value of MYD88 and CD79B mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma.
Marina Knudsen Kirkegaard, Marthe Minderman, Lene Dissing Sjö, Steven T Pals, Patrick R G Eriksen, Steffen Heegaard. Br J Ophthalmol 2021
0

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.
Wyndham H Wilson, George W Wright, Da Wei Huang, Brendan Hodkinson, Sriram Balasubramanian, Yue Fan, Jessica Vermeulen, Martin Shreeve, Louis M Staudt. Cancer Cell 2021
39

Update on Novel Therapeutics for Primary CNS Lymphoma.
Lauren R Schaff, Christian Grommes. Cancers (Basel) 2021
5

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis.
Joost S Vermaat, Sebastiaan F Somers, Liesbeth C de Wreede, Willem Kraan, Ruben A L de Groen, Anne M R Schrader, Emile D Kerver, Cornelis G Scheepstra, Henriëtte Berenschot, Wendy Deenik,[...]. Haematologica 2020
35